Creative Biolabs-Immuno-oncology

Luciferase Reporter Assay Service for GPCR-Ligand Interacting Detection

Introduction What We Can Offer Workflow Required Materials Publication Highlights Customer Reviews FAQs Extended Services

Introduction of Luciferase Reporter Assay

Luciferase reporter assays have become a gold standard in detecting GPCR-ligand interactions, offering an effective way to study GPCR activation in real time. These assays use luciferase enzymes to produce bioluminescence in response to receptor activation, providing quantitative data on ligand efficacy. Scientists have validated the method's efficiency in high-throughput screening and drug discovery, making it an essential tool in modern biopharmaceutical development. Are you facing challenges in detecting GPCR-ligand interactions and optimizing drug candidates? Luciferase reporter assay services at Creative Biolabs streamline the detection of GPCR activation and ligand binding through advanced bioluminescence technologies, helping you accelerate drug discovery and optimize compound screening with high sensitivity and reliability.

With our luciferase reporter assay services, you can:

What We Can Offer

At Creative Biolabs, we offer specialized luciferase reporter assay services designed to provide detailed insights into GPCR-ligand interactions. Our services include:

Discover How We Can Help - Request a Consultation

Workflow

1. Target GPCR Selection

We collaborate with you to select the most relevant GPCR for your study, considering therapeutic goals and existing data.

2. Assay Customization

Based on the selected GPCR, we design a customized luciferase reporter assay tailored to your needs, ensuring the assay is optimized for sensitivity and specificity.

3. Compound Screening

We perform high-throughput screening of your compound library to identify potential ligands for the target GPCR.

4. Real-Time Data Collection

The assay provides continuous real-time data, capturing changes in cellular activity with high accuracy to track GPCR activation.

5. Data Analysis & Reporting

Our team of experts analyzes the data, providing you with detailed reports that highlight potential candidates and their activity profiles.

Required Starting Materials

Publication

By expressing the Eluc-N-ARRB1 fusion protein in CHO and HEK293 cells with the MAC vector, luciferase activity can be measured in response to receptor-ligand interactions. This approach successfully detected luciferase signals in both cell types, demonstrating its ability to quantify protein interactions with high sensitivity. This method is valuable for studying GPCR signaling and can be applied in high-throughput screening and drug discovery.

Fig.1 Evaluation of luciferase activity of Eluc-N-ARRB1 expressed in CHO and HEK293 cells using the MAC vector. (OA Literature)Fig.1 Assessment of luciferase activity of Eluc-N-ARRB1 expressed from the MAC vector in CHO and HEK293 cells.1

Highlights

Advanced Technology

We utilize state-of-the-art bioluminescence and reporter assay technologies to ensure precise, reliable results. Our advanced platforms offer cutting-edge techniques for real-time monitoring of GPCR activation, delivering high-quality data that empowers your research and drug discovery efforts.

High Sensitivity and Accuracy

Detect even subtle GPCR-ligand interactions with minimal background interference. Our assays provide exceptional sensitivity, allowing you to identify weak or transient receptor activations that could be missed by other methods, ensuring accurate results for compound efficacy screening.

Service Features

Customizable Assays for Specific Targets

Our assays are fully customizable, ensuring compatibility with your unique research needs and offering flexibility across a broad spectrum of therapeutic targets.

Real-Time Data for Enhanced Decision Making

Our luciferase assays allow for real-time tracking of ligand-GPCR interactions, offering dynamic insights into receptor activation. This allows you to assess compound efficacy and kinetics in real-time, improving decision-making and optimizing drug candidate selection.

Experience the Creative Biolabs Advantage - Get a Quote Today

Customer Reviews

  1. Improved Screening Efficiency
    Using Creative Biolabs' Luciferase Reporter Assay in our research has significantly improved our high-throughput screening efficiency. We identified several promising GPCR-targeting compounds faster than before.
    Sarah T., 2024.
  2. Accurate Data for Compound Optimization
    The real-time data collection from the Luciferase Reporter Assay provided us with the necessary insights to refine our lead compounds, resulting in more selective GPCR agonists.
    Dr. M.K., 2023.
  3. Reliable and Customizable Service
    The customized luciferase assays offered by Creative Biolabs were essential in our drug discovery project. The high sensitivity of the assays helped us detect low-affinity interactions with ease. Liam G., 2024.

FAQs

Q: What is the main advantage of using luciferase reporter assays for GPCR studies?

A: Luciferase reporter assays offer high sensitivity and real-time monitoring, making them ideal for detecting subtle GPCR-ligand interactions and optimizing drug candidates.

Q: How customizable are the luciferase assays for specific GPCR targets?

A: Our assays are fully customizable to suit the specific characteristics of any GPCR target, ensuring reliable and relevant results for your research.

Q: Can these assays be used for high-throughput screening?

A: Yes, our luciferase reporter assays are designed for high-throughput screening, allowing you to evaluate large compound libraries efficiently.

Q: What types of data can I expect from the luciferase assay?

A: You will receive real-time, quantitative data on receptor activation, which will help identify potential drug candidates and inform further optimization.

Extended Services

At Creative Biolabs, we offer luciferase reporter assay services that can enhance the efficiency of your GPCR-ligand interaction studies. From assay design to high-throughput screening and data analysis, our solutions are crafted to accelerate your drug discovery efforts. Feel free to reach out for a consultation or to learn more about how we can help optimize your drug discovery process.

Reference

  1. Uno, Narumi, et al. "A luciferase complementation assay system using transferable mouse artificial chromosomes to monitor protein–protein interactions mediated by G protein-coupled receptors." Cytotechnology 70 (2018): 1499-1508. DOI: 10.1007/s10616-018-0231-7. Distributed under Open Access license CC BY 4.0, without modification.

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving